Journal of Traditional Chinese Medicine ›› 2022, Vol. 42 ›› Issue (3): 472-478.DOI: 10.19852/j.cnki.jtcm.20220408.001
• Research Article • Previous Articles Next Articles
ZHAO Yufeng1(), PANG Huaxin2, Lü Lanting3, ZHOU Pei1, WANG Kaining1,4, CAI Shengxing1,4, ZHANG Huifeng1, LI Kun5()
Received:
2021-08-19
Accepted:
2021-11-11
Online:
2022-06-15
Published:
2022-04-08
Contact:
ZHAO Yufeng,LI Kun
About author:
LI Kun, China Academy of Chinese Medical Sciences, Beijing 100700, China. kunlee_bj@163.com;Telephone: +86-10-64089654; +86-10-64089779Supported by:
ZHAO Yufeng, PANG Huaxin, Lü Lanting, ZHOU Pei, WANG Kaining, CAI Shengxing, ZHANG Huifeng, LI Kun. Risk assessment and analysis of Traditional Chinese Medicine intervention in coronavirus disease[J]. Journal of Traditional Chinese Medicine, 2022, 42(3): 472-478.
Premier risk assessment | Quarantine measures | TCM intervention | Risk assessment with intervention | Advantages | Limitation |
---|---|---|---|---|---|
I (max) = 300 000 R = 2.2 | Quarantine of infected patients at home | I (max) = 250 000 R = 1.9 | |||
I (max) = 300 000 R = 2.2 | Quarantine of infected patients at home | Y | I (max) = 220 000 R = 1.6 | Economy relatively stable | People's lives in great danger and national medical resources in short supply |
I (max) = 300 000 R = 2.2 | Quarantine of infected patients' families | I (max) = 230 000 R = 1.65 | |||
I (max) = 300 000 R = 2.2 | Quarantine of infected patients' families | Y | I (max) = 200 000 R = 1.47 | Economy less affected but relatively stable | People's lives in great danger and national medical resources in short supply |
I (max) = 300 000 R = 2.2 | Isolation of children at home after school closure | I (max) = 180 000 R = 1.35 | |||
I (max) = 300 000 R = 2.2 | Isolation of children at home after school closure | Y | I (max) = 150 000 R = 1.26 | Economy affected | People's lives in great danger and national medical resources in short supply |
I (max) = 300 000 R = 2.2 | Isolation of the senior over 70 years old | I (max) = 160 000 R = 1.3 | |||
I (max) = 300 000 R = 2.2 | Isolation of the senior over 70 years old | Y | I (max) = 120 000 R = 1.1 | Economy greatly affected | People's lives in relative danger and regional medical resources in short supply |
I (max) = 300 000 R = 2.2 | Regional or national communities lockdown | I (max) = 90 000 R = 0.82 | |||
I (max) = 300 000 R = 2.2 | Regional or national communities lockdown | Y | I (max) = 70 000 R = 0.73 | Economy greatly affected | People's lives in relative protected and safe, medical resources in short supply only in severe areas |
Table 1 Epidemic risk assessment with the combination of multiple quarantine measures and Traditional Chinese Medicine intervention
Premier risk assessment | Quarantine measures | TCM intervention | Risk assessment with intervention | Advantages | Limitation |
---|---|---|---|---|---|
I (max) = 300 000 R = 2.2 | Quarantine of infected patients at home | I (max) = 250 000 R = 1.9 | |||
I (max) = 300 000 R = 2.2 | Quarantine of infected patients at home | Y | I (max) = 220 000 R = 1.6 | Economy relatively stable | People's lives in great danger and national medical resources in short supply |
I (max) = 300 000 R = 2.2 | Quarantine of infected patients' families | I (max) = 230 000 R = 1.65 | |||
I (max) = 300 000 R = 2.2 | Quarantine of infected patients' families | Y | I (max) = 200 000 R = 1.47 | Economy less affected but relatively stable | People's lives in great danger and national medical resources in short supply |
I (max) = 300 000 R = 2.2 | Isolation of children at home after school closure | I (max) = 180 000 R = 1.35 | |||
I (max) = 300 000 R = 2.2 | Isolation of children at home after school closure | Y | I (max) = 150 000 R = 1.26 | Economy affected | People's lives in great danger and national medical resources in short supply |
I (max) = 300 000 R = 2.2 | Isolation of the senior over 70 years old | I (max) = 160 000 R = 1.3 | |||
I (max) = 300 000 R = 2.2 | Isolation of the senior over 70 years old | Y | I (max) = 120 000 R = 1.1 | Economy greatly affected | People's lives in relative danger and regional medical resources in short supply |
I (max) = 300 000 R = 2.2 | Regional or national communities lockdown | I (max) = 90 000 R = 0.82 | |||
I (max) = 300 000 R = 2.2 | Regional or national communities lockdown | Y | I (max) = 70 000 R = 0.73 | Economy greatly affected | People's lives in relative protected and safe, medical resources in short supply only in severe areas |
Item | China | Wuhan | Ot-Pro | Ot-City |
---|---|---|---|---|
R_mean | 2.27 | 2.43 | 1.79 | 2.19 |
R_std | 2.22 | 4.23 | 1.76 | 2.44 |
R_CI_95% | 1.96, 2.57 | 1.85, 3.01 | 1.55, 2.03 | 1.85, 2.53 |
Table 2 Number of basic infections in different areas
Item | China | Wuhan | Ot-Pro | Ot-City |
---|---|---|---|---|
R_mean | 2.27 | 2.43 | 1.79 | 2.19 |
R_std | 2.22 | 4.23 | 1.76 | 2.44 |
R_CI_95% | 1.96, 2.57 | 1.85, 3.01 | 1.55, 2.03 | 1.85, 2.53 |
Item | 100 | 500 | 1000 | 2000 |
---|---|---|---|---|
R_mean | 2.23 | 2.28 | 2.29 | 2.28 |
R_std | 2.41 | 1.79 | 0.81 | 0.81 |
R_CI_95% | 1.76, 2.70 | 2.12, 2.44 | 2.25, 2.35 | 2.24, 2.32 |
Table 3 Change of R with different N in China
Item | 100 | 500 | 1000 | 2000 |
---|---|---|---|---|
R_mean | 2.23 | 2.28 | 2.29 | 2.28 |
R_std | 2.41 | 1.79 | 0.81 | 0.81 |
R_CI_95% | 1.76, 2.70 | 2.12, 2.44 | 2.25, 2.35 | 2.24, 2.32 |
1 | WHO. Cumulative number of reported probable cases of severe acute respiratory syndrome (SARS). 2020-02-23. https://www.who.int/csr/sars/country/en/. |
2 | The Asian Development Bank. SARS: economic impacts and implications. 2020-02-23. https://www.adb.org/publications/sars-economic-impacts-and-implications. |
3 | Ren PH, Li ZQ, Zhu HP, Wang P, Qiu ZN, Zhang ZM. The rule of TCM treatment for Corona Virus Disease 2019 based on the theory of pestilence. Jinan Da Xue Xue Bao (Zi Ran Ke Xue Yu Yi Xue Ban) 2020; 41: 144-50+162. |
4 | Shi ZF, Dai QG, Zhong CM, Zhang XY, Zhao C, Shang HC. The qualitative research of the prevention and treatment of traditional Chinese medicines on Corona Virus Disease 2019 using software Nvivo. Jinan Da Xue Xue Bao (Zi Ran Ke Xue Yu Yi Xue Ban) 2020; 41:163-74. |
5 | Zou L, Yu X, Wu YQ, Sun D, Wu YG, Fang H. Analysis and thinking on Traditional Chinese Medicine in preventing and treating severe cases of novel coronavirus pneumonia. Shanghai Zhong Yi Yao Da Xue Xue Bao 2020; 34:11-6. |
6 | Zhang LL, Li C, Li J, et al. Experience in Treating COVID-19 by Stages. Zhong Yi Yao Xin Xi 2020; 37:17-20. |
7 |
Kumar A, Goel K, Nilam. A deterministic time-delayed SIR epidemic model: mathematical modeling and analysis. Theor Biosci 2020; 139:67-76.
DOI URL |
8 | Qun L, Daqing J, Tasawar H, Ahmed A, Bashir A. A stochastic SIRS epidemic model with logistic growth and general nonlinear incidence rate. Physica A 2020; 551. |
9 |
Elazzouzi A, Lamrani Alaoui A, Tilioua M, Tridane A. Global stability analysis for a generalized delayed SIR model with vaccination and treatment. Adv Differ Equ 2019; 2019:532.
DOI URL |
10 | Kermack WO, Mckendrick A GA. A contribution to the mathematical theory of epidemics. P Roy Soc A-Math phy 1927; 115:700-21. |
11 | Liu WL, Li XC, Zhang Y, et al. Thoughts on Traditional Chinese Medicine treatment of COVID-19 in Liao Shen area. Shanghai Zhong Yi Yao Za Zhi 2020; 54: 27-9+35. |
12 | Yu XY, Xu YL, Li XJ, Yang PY, Zhang X, Jia YJ. Analysis of TCM prevention and control measures for lung cancer patients under novel coronavirus epidemic situation. Tianjin Zhong Yi Yao 2020; 37:1213-6. |
13 | Ni GH, Wang YG, Shaanxi plays the role of traditional Chinese medicine in epidemic prevention and control. Zhong Yi Yao Guan Li Za Zhi 2020; 28:86. |
14 | Zhang BL. What role has Chinese medicine played in the prevention and treatment of the new crown pneumonia epidemic. Study Times, 2020-03-18. cited 2021-05-30; 9: 34 screens. Available from URL: http://www.satcm.gov.cn/xinxifabu/meitibaodao/2020-03-18/14043.html. |
15 | Yang FG, Huang M, Zhang JH. Advantages of the treatment with Traditional Chinese Medicine on novel coronavirus neumonia outbreak: academician Zhang Boli answered authoritatively. Tianjin Zhong Yi Yao 2020; 37:363-4. |
16 | Dean of Santai County Hospital of Traditional Chinese Medicine, Mianyang City, Sichuan Province LU Wenhua. Traditional Chinese Medicine to Build “Firewall” to Fight Epidemic in Online Domain. Health Newspaper, 2020(005). |
17 | Qin YH. Give Full Play to the characteristic advantages of Traditional Chinese Medicine and firmly win the fight against epidemic situation. Hunan Daily, 2020-02-20. cited 2021-05-30; 9: 50 screens. Available from URL:https://news.hnucm.edu.cn/info/1018/9737.htm. |
18 | Xia WG, An CQ, Zheng CJ, et al. Clinical Observation on 34 Patients with Novel Coronavirus Pneumonia (COVID-19) Treated with Intergrated Traditional Chinese and Western Medicine. Zhong Yi Za Zhi 2020; 61:375-82. |
19 |
Zhao S, Lin Q, Ran J, et al. Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: a data-driven analysis in the early phase of the outbreak. Int J Infect Dis 2020; 92:214-7.
DOI PMID |
20 |
Wu JT, Kathy L, Leung GM. Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study. Lancet 2020; 395:689-97.
DOI URL |
[1] | FAN Rong, HE Haoyu, TANG Tao, CUI Hanjin. Long-term effects of Qingfei Paidu decoction (清肺排毒汤) in patients with coronavirus disease 2019 acute pneumonia after treatment: a protocol for systematic review and Meta-analysis [J]. Journal of Traditional Chinese Medicine, 2023, 43(6): 1068-1071. |
[2] | SUN Wu, ZHAO Yuwei, LIAO Liang, ZHAO Zhonghui, CHEN Shiqi, YAN Xiaoling, WANG Xueyao, CHAO Guojun, ZHOU Jian. Effectiveness and safety of Xuebijing injection for patients with coronavirus disease 2019: a systematic review and Meta-analysis [J]. Journal of Traditional Chinese Medicine, 2023, 43(4): 631-639. |
[3] | ZHANG Yuehong, SHAO Xianzhi, ZHAO Qianlong, ZHAN Hualong, ZHANG Jianhua, DU Sisi, CHEN Jing, LIU Yingfang, ZHOU Haiwang, CHEN Xinsheng, HONG Ying, LIAN Fengmei, TONG Xiaolin, BA Yuanming. Effectiveness of Xiangsha Liujun pills (香砂六君丸) on decreased digestive function in convalescent patients of coronavirus disease 2019: a randomized, double blind, placebo controlled clinical trial [J]. Journal of Traditional Chinese Medicine, 2023, 43(3): 552-558. |
[4] | XU Guihua, CHEN Feifei, ZHANG Wei, WU Yingen, CHEN Xiaorong, SHI Kehua, WANG Zhenwei, SHI Miaoyan, ZHANG Xing, LU Yunfei, YUAN Weian, LYU Hua, CHEN Xuan. Effectiveness of Traditional Chinese Medicine on coronavirus disease 2019 in 92 patients: a retrospective study [J]. Journal of Traditional Chinese Medicine, 2023, 43(3): 582-587. |
[5] | YANG Cunqing, LIAN Fengmei, YANG Guiping, HUANG Yufeng, ZHANG Shuangbin, WANG Jianghua, ZHOU Jing, GUO Dongqing, SHEN Chuanyun, YE Tiansong, FU Aojie, LI Xiaoli, CHEN Le, ZHANG Huifeng, TU Qiyin, WANG Ying, YANG Wenzhe, TONG Xiaolin, BA Yuanming. Effectiveness of Xiaoyao capsule (逍遥丸) on sleep disorders and mood disturbance in patients in recovery from coronavirus disease 2019: a randomized controlled trial [J]. Journal of Traditional Chinese Medicine, 2023, 43(2): 343-351. |
[6] | ZHANG Yuehong, DONG Dandan, YAN Youqin, ZHANG Hao, WANG Guangli, ZHOU Wei, LI Wei, QIU Li, LI Tingming, LIU Quan, XIA Ping, MAO Lina, YANG Danlin, YANG Lu, LIAN Fengmei, TONG Xiaolin, BA Yuanming. Effectiveness and safety of Jinshuibao capsules (金水宝胶囊) in treatment of residual cardiopulmonary symptoms in convalescent patients of coronavirus disease 2019: a pilot randomized, double-blind, placebo-controlled clinical trial [J]. Journal of Traditional Chinese Medicine, 2023, 43(1): 134-139. |
[7] | AN Xuedong, MAO Lina, XIA Ping, SU Wen, WANG Beibei, KOU Leiya, ZHANG Zequan, QI Meng, HU Song, CHEN Jing, LI Xiujuan, LIU Jinwei, ZHOU Juan, QIAO Jie, LUO Dan, LUO Guangwei, YAN Youqin, YANG Guiping, DONG Dandan, ZHOU Wei, TAO Junxiu, JIN De, TONG Xiaolin, WEI Li. Effects of Shengmai Yin (生脉饮) on pulmonary and cardiac function in coronavirus disease 2019 convalescent patients with cardiopulmonary symptoms: a randomized, double blind, multicenter control trial [J]. Journal of Traditional Chinese Medicine, 2023, 43(1): 140-145. |
[8] | LI Ximeng, KANG Yuan, LI Wenjing, LIU Zhuangzhuang, XU Zhenlu, ZHANG Xiaoyu, CAI Runlan, GAO Yuan, QI Yun. Comparing the effects of three decoctions for coronavirus disease 2019 on severe acute respiratory syndrome coronavirus 2-related toll-like receptors-mediated inflammations [J]. Journal of Traditional Chinese Medicine, 2023, 43(1): 51-59. |
[9] | ZHU Qingguang, ZHANG Shuaipan, LI Jingxian, SUN Wuquan, CHENG Wei, ZHAN Chao, CHENG Yanbin, FANG Lei, FANG Min. Effectiveness of Liu-zi-jue exercise on coronavirus disease 2019 in the patients: a randomized controlled trial [J]. Journal of Traditional Chinese Medicine, 2022, 42(6): 997-10053. |
[10] | AN Xuedong, ZHANG Qing, TAO Junxiu, LI Li, CHEN Yun, LI Kejian, HE Jing, LIU Ru, GUO Juan, ZHANG Jia, ZHU Hui, LIAN Fengmei, LI Xiaodong. Shugan Jieyu capsule (舒肝解郁胶囊) improve sleep and emotional disorder in coronavirus disease 2019 convalescence patients: a randomized, double-blind, placebo-controlled trial [J]. Journal of Traditional Chinese Medicine, 2022, 42(5): 803-809. |
[11] | CHEN Huang, SHI Lushaobo, SHI Zengping, XIA Yi, WANG Dong. Factors influencing physician's behavioral intention to use Traditional Chinese Medicine to treat coronavirus disease 2019 based on the theory of planned behavior [J]. Journal of Traditional Chinese Medicine, 2022, 42(4): 633-6400. |
[12] | XIA Wenguang, ZHENG Chanjuan, ZHANG Jixian, HUANG Min, LI Qinglin, DUAN Can, LI Zhengliang, FAN Cunyu, ZOU Yilong, XU Bo, YANG Fengwen, LIU Qingquan. Randomized controlled study of a diagnosis and treatment plan for moderate coronavirus disease 2019 that integrates Traditional Chinese and Western Medicine [J]. Journal of Traditional Chinese Medicine, 2022, 42(2): 234-241. |
[13] | YAN Shixing, Lü Yi, LIU Ziqing, REN Meng, HE Haiyang, XIAO Li, GUO Feng, PENG Miao, LI Xiaoxia, WANG Yong, XU Xi, YANG Tao, SHAO Zuoyu, HUANG Jingjing, XIAO Mingzhong. Mining intrinsic information of convalescent patients after suffering coronavirus disease 2019 in Wuhan [J]. Journal of Traditional Chinese Medicine, 2022, 42(2): 279-288. |
[14] | LI Li, AN Xuedong, ZHANG Qing, TAO Junxiu, HE Jing, CHEN Yun, LI Kejian, LIU Ru, GUO Juan, ZHANG Hao, TONG Xiaolin, BA Yuanming. Shumian capsule(舒眠胶囊) improves symptoms of sleep mood disorder in convalescent patients of Corona Virus Disease 2019 [J]. Journal of Traditional Chinese Medicine, 2021, 41(6): 974-981. |
[15] | BAO Chunmiao, LI Binbin. Traditional Chinese Medicine enhances absorption of lung lesions in corona virus disease 2019 patients [J]. Journal of Traditional Chinese Medicine, 2021, 41(6): 982-984. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||
Sponsored by China Association of Chinese Medicine
& China Academy of Chinese Medical Sciences
16 Nanxiaojie, Dongzhimen Nei, Beijing, China. 100700 Email: jtcmen@126.com
Copyright 2020 Journal of Traditional Chinese Medicine. All rights reserved.